logo

For the Inventor, By the Inventor

Marburg, Germany

Behring Diagnostics Gmbh


USPTO Granted Patents = 39

% Expired Patents = 2.6

Trademarks = 1

Forward Citations = 340

Loading Chart...
Loading Chart...

84 inventors (with patents filed for the assignee):

goldMedal Bernhard W Fleckenstein (6 out of 19 patents)

silverMedal Frank Neipel (5 out of 6 patents)

bronzeMedal Peter Hermentin (4 out of 17 patents)

4.  Edwin F Ullman (4 out of 199 patents)

5.  Hans-Peter Hauser (3 out of 25 patents)

6.  Klaus Bosslet (3 out of 37 patents)

7.  Stefan Brust (3 out of 14 patents)

8.  Stefan Knapp (3 out of 23 patents)

9.  Lutz G Guertler (3 out of 14 patents)

10.  Gerhard Seemann (3 out of 19 patents)

11.  Josef Eberle (3 out of 13 patents)

12.  Albrecht V Brunn (3 out of 9 patents)

13.  Klaus Habenstein (3 out of 16 patents)

14.  Stephan Neuenhofer (2 out of 7 patents)

15.  Michael Kraus (2 out of 16 patents)


Core Competencies:
Viral Interleukin-6
Immunoassays
Monoclonal Antibodies
Human Herpesvirus
Gene Banks
Retrovirus
Nucleic Acid Amplification
Protein Detection
Lacrimal Fluid Analysis
Heavy Metal Removal
Acoustic Sensing
Automated Analytical Instruments

39 patents:

1. 7968696 - Viral interleukin-6 (2011-06-28),
2. 7109002 - Viral interleukin-6 (2006-09-19),
3. 6174685 - Human herpesvirus type 6 protein p100, the corresponding DNA sequences, their preparation and use (2001-01-16),
4. 6033890 - Homogeneous immunoassays using mutant glucose-6-phosphate dehydrogenases (2000-03-07),
5. 6030774 - Method for introducing defined sequences at the 3' end of polynucleotides (2000-02-29),
6. 6010868 - Method for stabilizing hydrolysis-sensitive molecules or molecular (2000-01-04),
7. 5989806 - Immunodissociation for improving the immunochemical determination of an (1999-11-23),
8. 5914243 - Process for the immunochemical determination of an analyte (1999-06-22),
9. 5908790 - Methods for removing heavy metals from aqueous solutions and for analysis (1999-06-01),
10. 5907034 - Monoclonal antibody against complexed and non-complexed complexing (1999-05-25),
11. 5895811 - Artificial positive controls derived from bifunctional conjugates (1999-04-20),
12. 5888753 - Monoclonal antibodies against the plasmin-antiplasmin complex, a method (1999-03-30),
13. 5869231 - Method for reproducibly determining the components of lacrimal fluid (1999-02-09),
14. 5858788 - Reagent for determining the ionic strength and/or the specific weight of (1999-01-12),
15. 5840508 - Compositions and methods for removal of detergents (1998-11-24),
Company Overview
Behring Diagnostics GmbH, based in Marburg, Germany, specializes in the development and manufacturing of innovative diagnostic solutions. The company focuses on enhancing laboratory diagnostics through advanced technologies, particularly in the fields of immunology and molecular diagnostics. With a commitment to quality and precision, Behring Diagnostics aims to support healthcare professionals in delivering accurate and timely patient care, contributing to improved health outcomes globally.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

39 Patents

#6 in Marburg

#1,305 in Germany

#17,465 in the World

Marburg, DE
Marburg, Germany

Behring Diagnostics Gmbh

Forward Citations = 340

84 inventors:

goldMedal Bernhard W Fleckenstein (6 out of 19 patents)

silverMedal Frank Neipel (5 out of 6 patents)

bronzeMedal Peter Hermentin (4 out of 17 patents)

4.  Edwin F Ullman (4 out of 199 patents)

5.  Hans-Peter Hauser (3 out of 25 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Behring Diagnostics Gmbh. Retrieved from https://idiyas.com/company/behring-diagnostics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…